These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The myelodysplastic syndromes and myeloproliferative disorders. Williams JL Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729 [TBL] [Abstract][Full Text] [Related]
23. The myelodysplastic syndromes. Part I. What are they? Part II. Classification. Galton DA Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515 [No Abstract] [Full Text] [Related]
24. Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes. Ogata K; Satoh C; Hyodo H; Tamura H; Dan K; Yoshida Y Leuk Res; 2004 Nov; 28(11):1171-5. PubMed ID: 15380341 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Germing U; Aul C; Niemeyer CM; Haas R; Bennett JM Ann Hematol; 2008 Sep; 87(9):691-9. PubMed ID: 18575866 [TBL] [Abstract][Full Text] [Related]
26. Myelodysplastic and myeloproliferative disorders in children. Hasle H Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes. Horny HP; Sotlar K; Valent P Leuk Res; 2007 Dec; 31(12):1609-16. PubMed ID: 17604834 [TBL] [Abstract][Full Text] [Related]
28. [Myelodysplastic syndrome classified based on FAB proposals: analysis of 58 cases]. Li TY; Gong SH; Zhao SR Zhonghua Nei Ke Za Zhi; 1985 Apr; 24(4):217-20, 255. PubMed ID: 4006614 [No Abstract] [Full Text] [Related]
29. [Classification of hemopoietic dysplasia and chronic myeloproliferative disorders]. Sawada H; Yamagishi M; Uchino H Nihon Rinsho; 1981 Aug; 39(8):2749-55. PubMed ID: 7038199 [No Abstract] [Full Text] [Related]
30. Myelodysplastic (preleukemia) syndromes: the bone marrow factory failure problem. Hoagland HC Mayo Clin Proc; 1995 Jul; 70(7):673-6; quiz 677. PubMed ID: 7791391 [TBL] [Abstract][Full Text] [Related]
31. Myelodysplastic syndrome: a review of 35 patients. Bursztyn M; Douer D; Ramot B Isr J Med Sci; 1987 Nov; 23(11):1140-4. PubMed ID: 3436796 [TBL] [Abstract][Full Text] [Related]
32. Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults. Shaw GR Br J Haematol; 2005 Oct; 131(2):180-4. PubMed ID: 16197447 [TBL] [Abstract][Full Text] [Related]
33. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity. Schmitt-Graeff A; Thiele J; Zuk I; Kvasnicka HM Haematologica; 2002 Apr; 87(4):392-9. PubMed ID: 11940483 [TBL] [Abstract][Full Text] [Related]
34. Classification of the myelodysplastic syndromes. Bennett JM Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370 [No Abstract] [Full Text] [Related]
35. The new WHO nomenclature: introduction and myeloid neoplasms. Rodak BF; Leclair SJ Clin Lab Sci; 2002; 15(1):44-54. PubMed ID: 12778956 [No Abstract] [Full Text] [Related]
36. Progenitor cells and classification of myelodysplastic and myeloproliferative disorders. Harris PF Lancet; 1985 Nov; 2(8466):1240. PubMed ID: 2866312 [No Abstract] [Full Text] [Related]
37. Effect of hydroxyurea on foetal haemoglobin in myeloproliferative & myelodysplastic syndromes. Advani SH; Venugopal P; Charak BS; Das Gupta A; Mazumdar AT; Gopal R; Nair CN; Saikia TK; Nadkarni KS; Kurkure PA Indian J Med Res; 1990 Apr; 92():83-5. PubMed ID: 1695200 [TBL] [Abstract][Full Text] [Related]
38. Progenitor cells and classification of myelodysplastic and myeloproliferative disorders. Brown G; Bunce CM; Rose PE; Howie AJ Lancet; 1985 Oct; 2(8460):885. PubMed ID: 2864593 [No Abstract] [Full Text] [Related]